Sale!

Drugs for Life: How Pharmaceutical Companies Define Our Health (Experimental Futures)

Amazon.com Price:  $19.21 (as of 12/05/2019 16:46 PST- Details)

Description

Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to achieve one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken as a right. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry’s literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and lack of confidence is a slightly new perception of ourselves as inherently unwell and in need of chronic remedy. This perception is based on clinical trials that we’ve got in large part outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they are going to create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can consider a life without prescription drugs.
Home » Shop » Books » Subjects » Politics and Social Sciences » Social Sciences » Anthropology » Cultural » Drugs for Life: How Pharmaceutical Companies Define Our Health (Experimental Futures)

Recent Products